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Vpx from HIV-2/SIVsm and Vpr from HIV-1 work in a
similar way. Their respective functions indeed require
the recruitment of the same cellular ubiquitin ligase,
assembled by cullin 4A. However both viral proteins are
not redundant from the functional point of view: Vpr
induces cell cycle arrest at the G2 phase of the cell
cycle, Vpx has no apparent effect on cell cycle progres-
sion. The specificity of their action results from their
capacity to recruit different cellular targets, which are
subsequently ubiquitinated and degraded. As such,
SAMHD1 was identified as the cellular restriction factor
specifically inactivated by Vpx, but not by HIV-1 Vpr.
The Vpr target whose degradation may lead to G2 arrest
is still unknown today, despite the discovery of several
cellular proteins degraded in the presence of the viral
protein. Among them, we identified two transcription
factors, ZIP and sZIP.
Ironically, it is the study of Vpx but not that of Vpr that
drives us back into the cell cycle field. Indeed, SAMHD1 is
a dNTP hydrolase, which restricts HIV-1 in quiescent cells
by depleting the intracellular pool of dNTP. In contrast,
SAMHD1 does not restrict the virus in cycling cells where
dNTP levels are abundant, reaching maximal concentra-
tions in S-phase when cells do replicate their DNA. This
led us to address the question of whether SAMHD1 con-
trols the proliferation status of the cell.
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